β³ Fetching live dividend data...
Home βΊ Calculator βΊ ONCSQ Dividend Calculator 2026
OncoSec Medical Incorporated Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ONCSQ β $1.0240512011520145e+51M in 10 years Β· $85,337,173,410,134,160,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
OncoSec Medical Incorporated was an immuno-oncology firm focused on the advanced stages of drug development. Its primary mission involved devising, perfecting, and bringing to market DNA-based treatments administered directly into tumors. These therapeutics were designed to activate and amplify the body's immune response to combat cancer effectively. The company's developmental portfolio was quite diverse. Key projects included KEYNOTE-695, which had reached Phase 2 trials for advanced melanoma, and several TAVO-based therapies. These included TAVO in combination with a SARS-CoV-2 spike glycoprotein, undergoing Phase 1 evaluation for COVID-19, and TAVO combined with epacadostat and pembrolizumab, also in Phase 1 for squamous cell carcinoma of the head and neck. Further investigational treatments comprised TAVO alongside nivolumab, in Phase 2 for breast cancer; TAVO with CXCL9, aimed at solid tumors; and the compounds OMS-100 and OMS-102, both in Phase 2 trials for metastatic melanoma. OncoSec forged significant clinical trial alliances with Merck & Co., Inc. and its subsidiary, particularly regarding KEYNOTE-695 and KEYNOTE-890. Additionally, a research partnership with Duke University's Center for Applied Therapeutics explored TAVO's potential when combined or sequenced with a HER2-plasmid vaccine. Originally established in 2008 as NetVentory Solutions Inc., the company adopted the name OncoSec Medical Incorporated in March 2011. Its corporate headquarters were situated in Pennington, New Jersey. Crucially, OncoSec Medical Incorporated ceased its operations following a voluntary petition for Chapter 7 liquidation. This petition was filed on June 14, 2023, with the U.S. Bankruptcy Court for the District of New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ONCSQ position with:
Real after-tax yield depends on where you live and how you hold ONCSQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 16000000.00% | 15999997.20% | $1,600,000,000 / yr |
| π¬π§ UK ISA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 18250000.00% | 18249997.20% | $1,825,000,000 / yr |
| π¨π¦ TFSA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 15000000.00% | 14999997.20% | $1,500,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 14725000.00% | 14724997.20% | $1,472,500,000 / yr |
| π«π· FR Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ONCSQ pays quarterly β 4 times per year. Next ex-div: TBD.
How ONCSQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ONCSQ sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ONCSQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
OncoSec Medical Incorporated (ONCSQ) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 20000000.00% based on an annual payout of $2.00 per share.
OncoSec Medical Incorporated (ONCSQ) is a healthcare stock currently trading at $0.00 with a dividend yield of 20000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever